On March 18, 2022, Michael Meluzio resigned as the Corporate Controller of Kiora Pharmaceuticals, Inc. to pursue other opportunities. Mr. Meluzio had served as the Company's principal financial officer and principal accounting officer on an interim basis beginning on February 25, 2022. Mr. Meluzio's resignation did not result from any disagreement regarding the Company's operations, policies or practices.

Effective as of March 18, 2022, Brian M. Strem, Ph.D., the Company's President and Chief Executive Officer, was appointed as the Company's principal financial officer and principal accounting officer.